The Latest Cardiac and Vascular News
VANCOUVER, British Columbia–(BUSINESS WIRE)–Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, announced today that it has raised an undisclosed amount in a new financing round. The financing was led by funds and accounts advised by T. Rowe Price Associates, Inc., and included participation from […]
SAN FRANCISCO, Feb. 07, 2019 (GLOBE NEWSWIRE) — InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases, today announced that new U.S. patents have been issued by the U.S. Patent and Trademark Office (USPTO). The two new patents provide the company with significantly expanded […]
VANCOUVER, Feb. 7, 2019 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced the presentation of clinical data highlighting the low rate of hospitalization in patients treated with Brinavess® (vernakalant hydrochloride, IV), its antiarrhythmic drug for the rapid conversion of recent onset atrial […]
CHICAGO–(BUSINESS WIRE)–Omron Healthcare, Inc. and physIQ Inc. today announced a collaboration to integrate Omron’s innovative FDA-cleared device, HeartGuide®, the first wearable blood pressure monitor into the pinpointIQ®platform to monitor at-risk patients in an outpatient setting. The strategic collaboration aims to generate actionable clinical information for at-risk patients in an outpatient environment by leveraging […]
PETAH TIKVA, Israel, Feb. 6, 2019 /PRNewswire/ — A groundbreaking piece of medical technology was revealed to the public today at the National Research Center for Cardiac Surgery in Astana, Kazakhstan. At a press conference held at the Center, top heart failure experts from around the world announced the successful implantation of FIVAD (Fully Implanted Ventricular Assist […]
IRVINE, Calif., Feb. 4, 2019 /PRNewswire/ — Johnson & Johnson Medical Devices Companies* announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, has enrolled and treated the first patient in its U.S. Investigational Device Exemption (IDE) study** which evaluates the company’s QDOT MICRO Radiofrequency […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ:ABMD) has achieved CE Mark for Impella Connect, the first-of-its kind cloud-based technology that enables secure, real-time, remote viewing of the Impella console for physicians and hospital staff from anywhere with Internet connectivity. European CE Mark adds to Impella Connect’s previous U.S. FDA PMA approval. Impella Connect uses […]
PARIS, Jan. 31, 2019 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat resistant hypertension and heart failure, today presents its 2019 corporate action plan. The end of 2018 was marked […]
CLEVELAND, Jan. 29, 2019 /PRNewswire/ — Recently renamed medical device company, S4 Medical, successfully completed its milestone development study, which demonstrated capability of protecting the esophagus from thermal damage during catheter ablation. Catheter ablation is an effective treatment for patients with atrial fibrillation (AF), but carries risk of esophageal injury due to […]
CARLSBAD, Calif., Jan. 28, 2019 /PRNewswire/ — Acutus Medical today announced 12-month data from the UNCOVER-AF trial investigating the use of the AcQMap advanced cardiac imaging and mapping visualization system in persistent atrial fibrillation (AF) ablation procedures. Results presented at the 24th Annual AF Symposium in Boston show the use of AcQMap resulted in 72.5 percent […]
